This is also associated with miRNA regulation, and it has been demonstrated that PRMT5 promotes lymphoma by increasing cyclin D1 and c-Myc expression through inhibition of miR-33b, miR-96, and miR-503 [127]. Here, PRMT5 is linked to lymphoma.